QA: Opiant Pharmaceuticals INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2019_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 29,370,578
1 IntangibleAssetsNetIncludingGoodwill 15,746
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 9,827,058
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,700,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,446,338
9 ResearchAndDevelopmentExpense 19,853,551
10 remainder_Expenses 38,814,697
11 remainder_Revenues 11,909,010
12 remainder_NetIncome 47,390
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,386,324
1 Liabilities 12,527,058
2 Expenses 68,114,586
3 Revenues 11,909,010
4 StockholdersEquity 16,859,266
5 NetIncome -56,158,186
6 ComprehensiveNetIncome -56,158,186
7 BaseVar 60,992,184
8 EconomicCapitalRatiobeforeLimitedLiability -0.926
9 EconomicCapitalRatio 1.32

Edgar->Model Mapping

Feature Distribution

Change over Time